Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

BUY
$47.98 - $54.4 $4.57 Million - $5.18 Million
95,170 New
95,170 $1.8 Million
Q4 2022

Jan 31, 2023

BUY
$68.48 - $81.09 $16,983 - $20,110
248 Added 8.53%
3,157 $227,000
Q3 2022

Nov 10, 2022

BUY
$0.13 - $76.84 $378 - $223,527
2,909 New
2,909 $225,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $126B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Global Assets Advisory, LLC Portfolio

Follow Global Assets Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Assets Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Assets Advisory, LLC with notifications on news.